Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells
Dendritic cells (DC) are usually regarded as antigen-presenting cells (APC) involved in T cell activation, but DC also directly or indirectly affect B cell function, antibody synthesis and isotype switch. In this study, we explore potential of DC-based immunotherapy in ongoing experimental autoimmun...
Main Authors: | Rui-Sheng Duan, Sanjaya Bandara Adikari, Yu-Min Huang, Hans Link, Bao-Guo Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-07-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996104000750 |
Similar Items
-
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1–T146
by: Alessandra Consonni, et al.
Published: (2017-09-01) -
Clinical characteristics of patients with myasthenia gravis associated with other autoimmune diseases
by: Li-li WANG, et al.
Published: (2014-10-01) -
Treatment of Autoimmune Myasthenia Gravis
by: J Gordon Millichap
Published: (2004-02-01) -
MYASTHENIA GRAVIS AND AUTOIMMUNE THYROID DISEASE
by: Tanja Hojs Fabjan, et al.
Published: (2001-12-01)